COX1 (mitochondrial cytochrome c oxidase subunit I) is a core component of Complex IV in the mitochondrial electron transport chain, catalyzing the final step of oxidative phosphorylation. COX1 functions as part of a binuclear catalytic center containing heme A3 and copper B that reduces molecular oxygen to water, accepting electrons from cytochrome c via the dinuclear copper A center [PMID:NCBI]. This electron transfer creates the electrochemical gradient essential for ATP synthesis and energy production. COX1 is encoded by mitochondrial DNA and its translation is specifically terminated by the specialized mitochondrial release factor mtRF1, which recognizes the non-conventional AGA stop codon unique to COX1 1. Loss of mtRF1-mediated termination causes isolated cytochrome c oxidase deficiency and triggers mitochondrial quality control mechanisms including COX1 mRNA degradation 1. Mutations in COX1 are associated with multiple mitochondrial diseases including Leber hereditary optic neuropathy, sensorineural deafness, mitochondrial complex IV deficiency, and recurrent myoglobinuria. The discovery of specific translation termination mechanisms for COX1 provides insights into mitochondrial biology and may inform understanding of disease pathogenesis in mitochondrial cytochrome c oxidase disorders.